@article{16c2ec6953c4436a99798608002b2741,
title = "Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial",
author = "Jackie Bosch and Pearce, {Lesly A.} and Mukul Sharma and Michelle Canavan and Whiteley, {William N.} and Robert Mikul{\'i}k and Hardi Mundl and Salim Yusuf and Hart, {Robert G.} and O'donnell, {Martin J.}",
note = "Funding Information: J.B. received fees for an Advisory Board and as an Adjudication Committee Member from Bayer, outside the submitted work. M.S. reports personal fees from BMS and Daichii Sankyo, outside the submitted work. M.C. received a travel grant from Boehringer Ingelheim and Bayer for conference attendance. W.W. is supported by a Scottish Senior Clinical Fellowship [CSO SCAF/17/01] and received grants from the Alzheimer's Society [UK], Chief Scientist's Office, UK MRC, and the UK Stroke Association. S.Y. is supported by the Heart & Stroke Foundation/Marion W. Burke Chair in Cardiovascular Disease and has received research grants, honoraria and travel expenses for lectures from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb AstraZeneca and Sanofi, outside the submitted work. R.H. reports grants and personal fees from Bayer AG, outside the submitted w Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",
year = "2022",
month = mar,
day = "12",
doi = "10.1016/j.jstrokecerebrovasdis.2022.106404",
language = "English",
volume = "31",
pages = "106404",
journal = "Journal of Stroke & Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "Elsevier",
number = "5",
}